Literature DB >> 9241736

The origin of P-selectin as a circulating plasma protein.

R Fijnheer1, C J Frijns, J Korteweg, H Rommes, J H Peters, J J Sixma, H K Nieuwenhuis.   

Abstract

P-selectin is a 140 kD protein found in the alpha-granules of platelets and the Weibel-Palade bodies of endothelial cells. On cell activation it is expressed on the cell surface and also secreted into plasma. Whether the circulating soluble P-selectin (sP-selectin) originates from platelets, endothelial cells, or both, is not known. We studied the level of sP-selectin in diseases with different platelet counts, with or without evidence of endothelial cell activation. Endothelial cell activation was confirmed by the detection of sE-selectin and ED1-fibronectin. A significant positive correlation between platelet count and sP-selectin concentration was observed in healthy controls, and in patients with thrombocytopenia due to bone marrow aplasia, or with thrombocytosis (r = 0.85; n = 47; p < 0.001). In patients with idiopathic thrombocytopenic purpura (ITP) the sP-selectin concentration was 110 +/- 39 ng/ml (n = 10), compared to 122 +/- 38 ng/ml in healthy controls (n = 26). However, their mean platelet count was lower (58 x 10(9)/l versus 241 x 10(9)/l in the control group). Accordingly, the levels of sP-selectin expressed per platelet increased to significantly higher levels (2.0 +/- 1.2 versus 0.6 +/- 0.2 fg/platelet in the control group; p < 0.0001). This suggests increased platelet turnover in patients with ITP. High levels of sP-selectin were found in patients with sepsis (398 +/- 203 ng/ml; n = 15) and with thrombotic thrombocytopenic purpura (TTP; 436 +/- 162 ng/ml; n = 12). Compared with patients with ITP, the concentration of sP-selectin per platelet was higher in patients with sepsis (4.8 +/- 4.3 fg/platelet; p < 0.005) or TTP (17.1 +/- 9.5 fg/platelet; p < 0.001). Endothelial cells are very likely to be the source in these patients and the presence of endothelial cell activation was confirmed by increased levels of circulating E-selectin and ED1-fibronectin. This study suggests that platelets are the major source of circulating sP-selectin in healthy individuals. Endothelial cell activation is associated with an increased sP-selectin concentration per platelet.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9241736

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  34 in total

1.  Pro-coagulant state resulting from high levels of soluble P-selectin in blood.

Authors:  P André; D Hartwell; I Hrachovinová; S Saffaripour; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

2.  Identification of diagnostic biomarkers for infection in premature neonates.

Authors:  Stephen F Kingsmore; Neil Kennedy; Henry L Halliday; Jennifer C Van Velkinburgh; Shengiang Zhong; Vanessa Gabriel; Judith Grant; William D Beavis; Velizar T Tchernev; Lorah Perlee; Serguei Lejnine; Brian Grimwade; Martin Sorette; J David M Edgar
Journal:  Mol Cell Proteomics       Date:  2008-07-13       Impact factor: 5.911

3.  Platelet count as a predictor of metastasis and venous thromboembolism in patients with cancer.

Authors:  Joanna L Sylman; Annachiara Mitrugno; Garth W Tormoen; Todd H Wagner; Parag Mallick; Owen J T McCarty
Journal:  Converg Sci Phys Oncol       Date:  2017-05-17

4.  Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome.

Authors:  C J M Frijns; R Fijnheer; A Algra; J A van Mourik; J van Gijn; G J E Rinkel
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

5.  Platelet activity and sensitivity to agonists after exhaustive treadmill exercise.

Authors:  Thomas Hilberg; Volker Schmidt; Wolfgang Lösche; Holger H W Gabriel
Journal:  J Sports Sci Med       Date:  2003-03-01       Impact factor: 2.988

6.  Differential sensitivity of various markers of platelet activation with adenosine diphosphate.

Authors:  Giang Le Minh; Alina D Peshkova; Izabella A Andrianova; John W Weisel; Rustem I Litvinov
Journal:  Bionanoscience       Date:  2018-12-10

7.  Lupus anticoagulant and history of thrombosis are not associated with persistent endothelial cell activation in systemic lupus erythematosus.

Authors:  C J Frijns; R H Derksen; P G De Groot; A Algra; R Fijnheer
Journal:  Clin Exp Immunol       Date:  2001-07       Impact factor: 4.330

8.  P-selectin and subclinical and clinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Suzette J Bielinski; Cecilia Berardi; Paul A Decker; Phillip S Kirsch; Nicholas B Larson; James S Pankow; Michele Sale; Mariza de Andrade; Hugues Sicotte; Weihong Tang; Naomi Q Hanson; Christina L Wassel; Joseph F Polak; Michael Y Tsai
Journal:  Atherosclerosis       Date:  2015-02-23       Impact factor: 5.162

9.  Circulating beta amyloid protein is elevated in patients with acute ischemic stroke.

Authors:  P H Lee; O Y Bang; E M Hwang; J S Lee; U S Joo; I Mook-Jung; K Huh
Journal:  J Neural Transm (Vienna)       Date:  2005-01-31       Impact factor: 3.575

10.  Correlations between plasma levels of a fibronectin isoform subpopulation and C-reactive protein in patients with systemic inflammatory disease.

Authors:  John H Peters; Tammy Greasby; Nancy Lane; Anthony Woolf
Journal:  Biomarkers       Date:  2009-06       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.